defunct biotechnology companies: mergers and acquisitions, business liquidation, insolvency, renaming

Defunct Biotechnology Companies

Cogent Neuroscience, Inc.	insolvency		2002
Collateral Therapeutics, Inc.	acquired by	Schering AG	2002
Consensus Pharmaceuticals, Inc.
Convergence Pharma	acquired by	Ilex Oncology, Inc.	1999
Corgentech, Inc.	renamed	Anesiva, Inc.	2006
Corvas International, Inc.	acquired by	Dendreon Corporation	2003
CoTherix, Inc.	acquired by	Actelion Pharmceuticals, Inc.	2006
Coulter Cellular Therapies, Inc.	renamed	Eligix, Inc.	1999
Creative BioMolecules, Inc.	merged	Curis, Inc.	2000
Creatogen AG	insolvency		2002
CroMedica	acquired by	PRA International	2002
CropTech Corp.	insolvency		2003
Cryogenic Solutions, Inc.	renamed	CytoGenix, Inc.	2000
Cutanogen Corp.	acquired by	Cambrex Corp.	2006
Cyclonal Pharmaceutics, Inc.	renamed	eXegenics, Inc.	2001
Cypros Pharmaceutical Corp.	merged to	Questcor Pharmaceuticals, Inc.	1999
Cytel Corporation	merged to	Epimmune, Inc.	1999
Cyternex, Inc.	renamed	Cylene Pharmaceuticals, Inc.	2003
Cytoprint, Inc.	acquired by	Atto Bioscience, Inc.	2003
CytoTherapeutics, Inc.	renamed	StemCells, Inc.	2000
CyVera Corporation	acquired by	Illumina, Inc.	2005
previous